Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
|
|
- Damon Gaines
- 5 years ago
- Views:
Transcription
1 Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
2 Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio offers a personal service to our customers with dedicated research managers who will work with you to source the best report for your needs. Based in the UK, BioPortfolio is well positioned to coordinate our customers' orders sourced from over 50 global report publishers. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0) or reportstore@bioportfolio.com 2
3 Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Karo Pharma AB (Karo Pharma), formerly Karo Bio AB, is a health care company that focuses on research and development of pharmaceutical products in the areas of cancer and inflammatory diseases. Its key research area involves nuclear receptors as target proteins for the development of new pharmaceuticals. Karo Pharma discovers drugs to target major diseases such as dyslipidemia; diabetes; autoimmune diseases such as rheumatoid arthritis, ulcerative colitis and multiple sclerosis; inflammation, multiple types of cancer, viral and bacterial infections. The company s projects are based on ROR gamma receptor and estrogen receptor. Its development pipeline also includes T268A Cold Spray which utilizes glucose oxidase enzyme in combination with glucose to fight against cold virus. Karo Pharma is headquartered in Huddinge, Stockholm, Sweden. Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary in-house Power etrack deals database, and primary and secondary research. Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company's operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of 3
4 the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Additional Details Publisher : Global Data Reference : GDPH59487D Number of Pages : 34 Report Format : PDF Publisher Information : 4
5 5
6 Table Of Contents for Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Table of Contents Table of Contents 2List of Tables 3List of Figures 4Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD Karo Pharma AB, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD Karo Pharma AB, Medical Devices Deals, 2010 to YTD Karo Pharma AB, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD Karo Pharma AB, Pharmaceuticals & Healthcare, Deal Details 12Partnerships 12Karo Bio Enters Into Research Agreement With 4D Science 12Karo Bio Extends Research Agreement With Pfizer For RORgamma Modulators 13Karo Bio Enters Into Research Agreement With Pfizer For RORgamma Modulators 14Karo Bio Extends Research Agreement With Zydus Cadila 16Karo Bio Terminates Its Collaboration With Merck & Co For MK Licensing Agreements 18Karo Bio Enters into Licensing Agreement with Pelago Bioscience for CETSA 18Karo Bio Enters Into Licensing Agreement With Alkem 19Equity Offering 21Karo Bio to Raise USD29.7 Million in Rights Offering of Preferred Shares 21Karo Bio Raises USD29 Million in Rights Offering of Shares 23Karo Bio Raises USD12 Million in Rights Offering of Shares 25Karo Bio Raises USD1 Million in Private Placement of Shares 26Karo Bio Completes Rights Offering of Shares for USD4.9 Million 27Karo Bio Completes Rights Offering Of US$49 Million 28Acquisition 30Karo Bio Acquires Tanomed for USD2.3 Million 30Karo Pharma AB - Key Competitors 31Key Employees 32Locations And Subsidiaries 33Head Office 33Other Locations & Subsidiaries 33Appendix 34Methodology 34About GlobalData 34Contact Us 34Disclaimer 34 6
7 List Of Tables in Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile List of Tables Karo Pharma AB, Pharmaceuticals & Healthcare, Key Facts, Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD Karo Pharma AB, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD Karo Pharma AB, Deals By Therapy Area, 2010 to YTD Karo Pharma AB, Medical Devices Deals, 2010 to YTD Karo Pharma AB, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD Karo Bio Enters Into Research Agreement With 4D Science 12 Karo Bio Extends Research Agreement With Pfizer For RORgamma Modulators 13 Karo Bio Enters Into Research Agreement With Pfizer For RORgamma Modulators 14 Karo Bio Extends Research Agreement With Zydus Cadila 16 Karo Bio Terminates Its Collaboration With Merck & Co For MK Karo Bio Enters into Licensing Agreement with Pelago Bioscience for CETSA 18 Karo Bio Enters Into Licensing Agreement With Alkem 19 Karo Bio to Raise USD29.7 Million in Rights Offering of Preferred Shares 21 Karo Bio Raises USD29 Million in Rights Offering of Shares 23 Karo Bio Raises USD12 Million in Rights Offering of Shares 25 Karo Bio Raises USD1 Million in Private Placement of Shares 26 Karo Bio Completes Rights Offering of Shares for USD4.9 Million 27 Karo Bio Completes Rights Offering Of US$49 Million 28 Karo Bio Acquires Tanomed for USD2.3 Million 30 Karo Pharma AB, Key Competitors 31 Karo Pharma AB, Key Employees 32 Karo Pharma AB, Subsidiaries 33 7
8 List Of Figures, Charts and Diagrams in Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile List of Figures Karo Pharma AB, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD Karo Pharma AB, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD Karo Pharma AB, Medical Devices Deals, 2010 to YTD
9 How to Buy... Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and it to us at reportstore@bioportfolio.com or Fax it to us at +44 (0) We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $250 Single User Price $500 Site License Price $750 Enterprise License Price Payment Options: (please tick one) Online Credit Card (we will you the invoice with a payment link) Direct Wire Transfer (we will you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0) We will be delighted to give you our personal attention. 9
Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio
More informationConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
ConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile ConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business
More informationNektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing
More informationAcadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio
More informationBionure Farma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Bionure Farma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bionure Farma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and
More informationNatera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business
More informationStarpharma Holdings Limited (SPL) - Medical Equipment - Deals and Alliances Profile
Starpharma Holdings Limited (SPL) - Medical Equipment - Deals and Alliances Profile Starpharma Holdings Limited (SPL) - Medical Equipment - Deals and Alliances Profile BioPortfolio has been marketing business
More informationGlenmark Pharmaceuticals Inc., USA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Glenmark Pharmaceuticals Inc., USA - Pharmaceuticals & Healthcare - Deals and Alliances Profile Glenmark Pharmaceuticals Inc., USA - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio
More informationDNA2.0 Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
DNA2.0 Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile DNA2.0 Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and market research
More informationNorth China Pharmaceutical Group Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
North China Pharmaceutical Group Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile North China Pharmaceutical Group Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio
More informationBessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing
More informationMedian Kliniken GmbH & Co. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Median Kliniken GmbH & Co. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Median Kliniken GmbH & Co. - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing
More informationPharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business
More informationEmcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing
More informationCollegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile The Business
More informationMesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile
Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile BioPortfolio has been marketing business
More informationFaes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Faes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Faes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business
More informationVanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sector Publishing Intelligence Limited
More informationBioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and market
More informationMesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile
Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile BioPortfolio has been marketing business
More informationBecton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio
More informationMindray Medical International Limited (MR) - Medical Equipment - Deals and Alliances Profile
Mindray Medical International Limited (MR) - Medical Equipment - Deals and Alliances Profile Mindray Medical International Limited (MR) - Medical Equipment - Deals and Alliances Profile BioPortfolio has
More informationDaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sector
More informationParamount Mining Corporation Limited (PCP) - Metals and Mining - Deals and Alliances Profile
Paramount Mining Corporation Limited (PCP) - Metals and Mining - Deals and Alliances Profile Paramount Mining Corporation Limited (PCP) - Metals and Mining - Deals and Alliances Profile Sector Publishing
More informationThe Walt Disney Company - Strategy, SWOT and Corporate Finance Report
The Walt Disney Company - Strategy, SWOT and Corporate Finance Report The Walt Disney Company - Strategy, SWOT and Corporate Finance Report The Business Research Store is run by Sector Publishing Intelligence
More informationGap, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Gap, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Gap, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Sector Publishing Intelligence
More informationKohler Co. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Kohler Co. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Kohler Co. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Sector Publishing Intelligence
More informationMcCain Foods Limited, Inc. - Strategic SWOT Analysis Review
McCain Foods Limited, Inc. - Strategic SWOT Analysis Review McCain Foods Limited, Inc. - Strategic SWOT Analysis Review Sector Publishing Intelligence Limited (SPi) has been marketing business and market
More informationPhone: +44 (0) or BioPortfolio Limited
Global Laser Holographic Display Market by Product (Medical Scanners, Digital Signage, Kiosk, Notebook), by Application (Medical, Commercial, Industrial, Defense, Consumer Electronics), by Geography -
More informationVorwerk and Co. KG - Strategy, SWOT and Corporate Finance Report
Vorwerk and Co. KG - Strategy, SWOT and Corporate Finance Report Vorwerk and Co. KG - Strategy, SWOT and Corporate Finance Report The Business Research Store is run by Sector Publishing Intelligence Ltd.
More informationMaruti Suzuki India Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Maruti Suzuki India Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Maruti Suzuki India Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment
More informationCompression Therapy - Medical Devices Pipeline Assessment, 2017
Compression Therapy - Medical Devices Pipeline Assessment, 2017 Compression Therapy - Medical Devices Pipeline Assessment, 2017 BioPortfolio has been marketing business and market research reports from
More informationSurgical Sutures Market By Product Type [Automated Suturing Devices (Disposable Automated Suturing Devices, And Re-Usable Automated Suturing
Surgical Sutures Market By Product Type [Automated Suturing Devices (Disposable Automated Suturing Devices, And Re-Usable Automated Suturing Devices), and Sutures (Sutures by Type (Absorbable & Non-Absorbable),
More informationCritical Limb Ischemia - Pipeline Review, H1 2017
Critical Limb Ischemia - Pipeline Review, H1 2017 Critical Limb Ischemia - Pipeline Review, H1 2017 BioPortfolio has been marketing business and market research reports from selected publishers for over
More informationJohnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile
Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile BioPortfolio has been marketing business and market research
More informationGenerics Series: Authorized Generics Analysis Stemming the Generics Tide
Generics Series: Authorized Generics Analysis Stemming the Generics Tide Report summary An overview of the authorized generics landscape, including drivers and resistors for both branded and generics players
More informationUnited States Sterilization Equipment Market Outlook to 2021
United States Sterilization Equipment Market Outlook to 2021 United States Sterilization Equipment Market Outlook to 2021 BioPortfolio has been marketing business and market research reports from selected
More informationPwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update
PwC Deals Q3 16 Update Executive summary Global Pharma and Life Sciences (PLS) deal activity declined both in volume and value this quarter compared to the prior quarter and Q3 15. The considerable decrease
More informationWOLPERT ASSOCIATES, INC. Strategic Advisory Services Firm Overview
Strategic Advisory Services 2018 Firm Overview Our Foundational Principles Strategic Advice for Biopharmaceutical, Medical Technology and Life Science sectors A Focus on Strategic Thinking in the Context
More informationImplantable Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Trends And Forecast,
Transparency Market Research Implantable Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 2018 Buy Now Request Sample Published Date: Mar 2013 Single User
More informationBayer Inc. Science for a Better Life. Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division
Bayer Inc. Science for a Better Life Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division Please review your career path to date, leading to your
More informationDigital Health Funding and M&A
Digital Health Funding and M&A 2018 Third Quarter and Nine Month Report Funding and Merger & Acquisition activity for the Digital Health sector http://www.mercomcapital.com 1 Copyright 2010-2016 Mercom
More informationState of Licensing 2011 Update
State of Licensing 2011 Update Moderators/Speakers Hemmie Chang, Chair, Licensing & Strategic Alliance Practice Group, Foley Hoag LLP Ranya Dajani, Executive Director, Strategic Transactions Group, Bristol-
More informationApril By Type of Approach- Transfemoral and Transapical. By Region- North America, Europe, APAC and RoW
Global Transcatheter Aortic Valve Replacement (TAVR) Market: Analysis By Type of Approach (Transfemoral and Transapical), By Region, By Country: Opportunities and Forecast (2017-2022) By Type of Approach-
More informationHBM Healthcare Investments Ltd Access to a Global and Diversified Private Equity Healthcare Portfolio
HBM Healthcare Investments Ltd Access to a Global and Diversified Private Equity Healthcare Portfolio SECA conference Zurich, 3 July 2013 Dr. Andreas Wicki, CEO HBM at a Glance SIX-listed investment company
More informationDealdoc. Acquisition agreement for Gambro. Baxter International Gambro. Dec , Wildwood Ventures Ltd. All rights reserved.
Dealdoc Acquisition agreement for Gambro Baxter International Gambro Dec 04 2012 Acquisition agreement for Gambro Companies: Baxter International Gambro Announcement date: Dec 04 2012 Deal value, US$m:
More informationIndoor Positioning and Navigation System Market Research Report- Forecast 2023
Report Information More information from: https://www.marketresearchfuture.com/reports/1775 Indoor Positioning and Navigation System Market Research Report- Forecast 2023 Report / Search Code: MRFR/SEM/1243-CRR
More informationGlobal Paper Stationery Market Research Report 2016
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Global Paper Stationery Market Research Report 2016 Global Paper Stationery Market Research Report 2016 Publication
More informationPerspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond
Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond ACI Forum on Structuring, Negotiating and Managing Life Sciences Collaborations and Acquisitions February 28,
More information2013 Global venture capital confidence survey results. How confident are investors?
2013 Global venture capital confidence survey results How confident are investors? August 14, 2013 Contents Survey methodology, demographics and key findings Economic trends Regional and country investing
More informationRoche's Global IP Strategy 10th. JIPA IP Symposium, Tokyo Dr. Axel Braun F. Hoffmann La Roche Ltd.
Roche's Global IP Strategy 10th. JIPA IP Symposium, Tokyo 2011 Dr. Axel Braun F. Hoffmann La Roche Ltd. Content Roche Company Profile The IP Department Patent Filings Global Strategy Sales Overview IP
More informationFall State of the Industry Report UF SID MARTIN FLORIDA BIODATABASE
Fall 2015 State of the Industry Report UF SID MARTIN FLORIDA BIODATABASE Industry Overview The expansion of Florida s biotech industry remains resilient with an overall growth rate of 92% in the number
More information1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Global Neurostimulation Devices Market - An Overview 3.
1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Global Neurostimulation Devices Market - An Overview 3.1 Spinal Cord Stimulator 3.2 Deep Brain Stimulator 3.3 Vagus Nerve Stimulator
More informationCherry AB. Investing in a broad gaming portfolio. CEO Anders Holmgren GP Bullhound 6 December 2017
Cherry AB Investing in a broad gaming portfolio CEO Anders Holmgren GP Bullhound 6 December 2017 The game is on Cherry is investing in a broad portfolio of online gaming companies Cherry s strategy is
More informationGlobal Absolute Pressure Transmitters Market Research Report 2016
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Global Absolute Pressure Transmitters Market Research Report 2016 Global Absolute Pressure Transmitters Market Research
More informationGlobal DAW Software Market Research Report 2016
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Global DAW Software Market Research Report 2016 Global DAW Software Market Research Report 2016 Publication ID:
More informationGLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS
GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS PHM006K March 2016 Himani Singhi Wadhwa Project Analyst ISBN: 1-62296-254-0 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481
More informationVentureSource Europe -- 3Q 2014
Europe -- 3Q 2014 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, and liquidity. The included charts and graphs offer a
More informationVenture Capital Report
Venture Capital Report Europe 1Q 2018 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included
More informationIntellectual property governance and strategic value creation:
Intellectual property governance and strategic value creation: some evidence from European organizations in, pharmaceutical and public research fields Dr. Federica Rossi (rossi.federica@unito.it) Universita
More informationPharma - Biotech Collaborations: Optimizing Success, Minimizing Risk and Maintaining Alignment
Presenter: Randall Sunberg Morgan Lewis May 16, 2008 In cooper Biography Randall Sunberg partner Morgan Lewis, Princeton Phone: 609.919.6606 Randall B. Sunberg is a partner in Morgan Lewis's Business and
More informationReinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D
Reinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D John C. Lechleiter, Ph.D. Chairman, President, and Chief Executive Officer Eli Lilly and Company Washington Biotechnology &
More informationAMCo current. Medpace new in Sebia realised. Spire Healthcare partially realised. Healthcare. Sector insights. Our Healthcare portfolio in 2014
Sector insights The healthcare market is highly complex with global products delivered through local services and channels. The healthcare value chain is intricate, diverse and interdependent. It is a
More informationVenture Capital Report
Venture Capital Report Europe 3Q 2015 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included
More informationTHE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION)
THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION) Feedback from 93 Eastern-European patient groups PUBLISHED JULY 2016 CONTENTS ABOUT THIS REPORT Page 1 WHAT DID
More informationHow attractive is the BioRegion of Catalonia for foreign investment? Guy Nohra Co-Founder and Managing Director of Alta Partners
How attractive is the BioRegion of Catalonia for foreign investment? Guy Nohra Co-Founder and Managing Director of Alta Partners How attractive is the BioRegion of Catalonia for foreign investment? M ost
More informationMilitary Robotics - Emerging Trends and Future Outlook. Reference code: DF4580PR Published: July 2015 Single user price: US$1950
Military Robotics - Emerging Trends and Future Outlook Reference code: DF4580PR Published: July 2015 Single user price: US$1950 1 Summary Military Robotics - Emerging Trends and Future Outlook is a report
More informationVenture Capital Report
Venture Capital Report China 2 Q 2018 The following report presents Dow Jones VentureSource s quarterly findings for Chinese venture capital fundraising, investment, valuation, and liquidity. The included
More informationGlobal Sequins Apparels Market Research Report 2016
Report Information More information from: https://www.wiseguyreports.com/reports/812531-global-sequins-apparels-market-research-report-2016 Global Sequins Apparels Market Research Report 2016 Report /
More informationJOHN JACK R. TUPMAN, JR CURRICULUM VITAE
JOHN JACK R. TUPMAN, JR CURRICULUM VITAE September 2018 John R. Tupman, Jr. is a consultant focused on business development and licensing in the life sciences industry. He is currently working as a consultant
More informationVenture Capital Report
Venture Capital Report China 1 Q 2018 The following report presents Dow Jones VentureSource s quarterly findings for Chinese venture capital fundraising, investment, valuation, and liquidity. The included
More informationWorld Offshore Wind Market Forecast Prospects, Technologies, World Markets
2016 World Offshore Wind Market Forecast 2016-2025 Prospects, Technologies, World Markets Contents Table of Contents 1 Summary and Conclusions...7 Summary... 8 Conclusions... 9 2 Drivers and Indicators...
More informationGlobal and China Industrial Robot Industry Report, Sep. 2013
Global and China Industrial Robot Industry Report, 2013 Sep. 2013 STUDY GOAL AND OBJECTIVES This report provides the industry executives with strategically significant competitor information, analysis,
More informationEXECUTIVE SUMMARY. Investment Opportunity. Paradox Financial Solutions Inc.
An innovative new system for Supply Chain Financing that is so disruptive that it will revolutionize the way in which practices in B2B trading relationships occur. has invented a system that revolutionizes
More informationPurvi B. Maniar Member of the Firm
Purvi B. Maniar Member of the Firm New York 250 Park Avenue New York, New York 10177 Tel: 212-351-3757 Fax: 212-878-8600 St. Louis Tel: 314-395-2775 pmaniar@ebglaw.com PURVI B. MANIAR is a Member of the
More informationChina Ophthalmic Hospital Industry Report, May 2013
China Ophthalmic Hospital Industry Report, 2012-2015 May 2013 STUDY GOAL AND OBJECTIVES This report provides the industry executives with strategically significant competitor information, analysis, insight
More informationFOREST LABORATORIES, INC. AND DAIICHI SANKYO, INC. ANNOUNCE THE TERMINATION OF THE AZOR CO-PROMOTION AGREEMENT
For Immediate Release Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Takashi Shoda, President and Representative Director (Code no.: 4568, First Section, Tokyo, Osaka and Nagoya Stock Exchanges)
More informationDigital Health Startups A FirstWord ExpertViews Dossier Report
AM PL E PA G ES S A G ES S A FirstWord ExpertViews Dossier Report Published Copyright 2016 Doctor s Guide Publishing Limited All rights reserved. No part of this publication may be reproduced or used in
More informationMara H. Rogers, Partner Norton Rose Fulbright
Mara H. Rogers Partner Norton Rose Fulbright US LLP New York T:+1 212 318 3206 F:+1 212 318 3400 mara.rogers@nortonrosefulbright.com vcard (+Outlook) Related services Corporate, M&A and securities Mergers
More informationQ&A with Samira Salman
APRIL 2017 VOL. 5 ISSUE 122 R E P O R T Q&A with Samira Salman Founder of Salman Solutions. Principle Series: Family Office Insights sits down with Samira Salman to discuss successful deal structuring
More informationRobert A. Greising Partner
Robert A. Greising Partner P: (317) 238-6215 F: (317) 636-1507 E: rgreising@kdlegal.com Indianapolis Office One Indiana Square Suite 2800 Indianapolis, IN 46204-2079 Robert Greising is a Partner in the
More informationLicensing League Tables 3Q14
BioPharm Insight Licensing League Tables Table of Contents League Tables Global League Tables of Legal Advisors for...2 Global League Tables of Legal Advisors for...3 North American League Tables of Legal
More informationNew York Bar admission (or eligibility to obtain admission promptly) is required.
Job Opportunities To apply to any of the positions send cover letter referencing job opening with resume and salary requirements to info@bryantrabbino.com Senior Level Corporate Finance Attorney We are
More informationSingular ID. The Story of Commercialising a Materials Technology in Singapore. Adrian Burden
2010 Bilcare Technologies. Privileged presentation, slide 1 Singular ID The Story of Commercialising a Materials Technology in Singapore Adrian Burden Co-founding Director of Singular ID President Europe
More informationRobert A. Greising Partner
Robert A. Greising Partner P: (317) 238-6215 F: (317) 636-1507 E: rgreising@kdlegal.com Indianapolis Office One Indiana Square Suite 2800 Indianapolis, IN 46204-2079 Robert Greising serves as a Partner
More informationCeQur establishes Wales subsidiary
FOR IMMEDIATE RELEASE CeQur establishes Wales subsidiary -- Arthurian Life Sciences investment helps bring to market world s first three-day simple insulin infusion device for type 2 diabetes -- LUCERNE,
More information2014 Global venture capital confidence survey results
2014 Global venture capital confidence survey results How confident are investors? August 13, 2014 Contents Survey methodology, demographics and key findings Economic trends Regional and country investing
More informationGrowing the pipeline, growing the bottom line. Shifts in pharmaceutical R&D innovation. kpmg.com KPMG INTERNATIONAL
Growing the pipeline, growing the bottom line Shifts in pharmaceutical R&D innovation kpmg.com KPMG INTERNATIONAL CONTENTS Page 4 The great research challenge Page 8 Organizational barriers to innovation
More informationAnnual Press Conference Financial year 2017
Annual Press Conference 2018 Financial year 2017 Financial year Hubertus von Baumbach Chairman of the Board of Managing Directors 2017 Highly successful financial year 2017 Major success with human pharmaceuticals
More informationMaster Class : Excellence in Private Equity & Deal Structuring
Master Class : Excellence in Private Equity & Deal Structuring Program Description: A strong understanding of private equity and deal structuring has become a necessity for all players in the financial
More informationPitchBook. Bet ter Data. Bet ter Decisions. 4Q 2012 Private Equity. Company Inventory. Report. Sponsored by:
4Q 2012 Private Equity Company Inventory Report Sponsored by: www.newstarfin.com Introduction In the last few quarters, an overwhelming number of the inquiries coming in to the Research Team have centered
More informationInnovation at TCS. Sharmila Mande Principal Scientist and Head- Bio Sciences R&D TCS Innovation Labs- Hyderabad
Innovation at TCS Sharmila Mande Principal Scientist and Head- Bio Sciences R&D TCS Innovation Labs- Hyderabad Outline About TCS TCS Innovation Story Innovation Labs TCS' Co Innovation Network TCS' Life
More informationGLOBAL RISK AND INVESTIGATIONS JAPAN CAPABILITY STATEMENT
GLOBAL RISK AND INVESTIGATIONS JAPAN CAPABILITY STATEMENT CRITICAL THINKING AT THE CRITICAL TIME ABOUT US The Global Risk and Investigations Practice (GRIP) of FTI Consulting is the leading provider of
More informationFinancing SMEs and Entrepreneurs 2012
Financing SMEs and Entrepreneurs 2012 AN OECD SCOREBOARD OECD Table of Contents Acronyms and abbreviations 13 Chapter 1. Financing SMEs and Entrepreneurs: Understanding and Developing an OECD Scoreboard
More informationI Overview. II Hallmarks of Turnpoint Group. III Corporate Financial Services. IV Assignments. V Clients. VI Market Segments
Content I Overview II Hallmarks of Turnpoint Group III Corporate Financial Services IV Assignments V Clients VI Market Segments VII Selection of transactions a. advising the seller b. advising the buyer
More informationData-Driven Evaluation: The Key to Developing Successful Pharma Partnerships
R&D Solutions for PHARMA & LIFE SCIENCES DRUG DISCOVERY & DEVELOPMENT Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships Summary For pharmaceutical companies to succeed, it is
More informationTransaction Services. Member of Invest Europe and SECA Swiss Priva te E quity & Corporate Finance Association
Transaction Services Profile BridgeLink M&A und Corporate Finance BridgeLink is an international service company providing comprehensive solutions in M&A and Corporate Finance. We are located in Basel
More informationLocal Production of Pharmaceuticals and Related Technology Transfer UNCTAD/CD-TFT 1. Background
Local Production of Pharmaceuticals and Related Technology Transfer Dr. Padmashree Gehl Sampath Division for Technology and Logistics UNCTAD UNCTAD/CD-TFT 1 1 Background Case studies part of the EU funded
More informationStrategic Alliance Agreement for the Generic Business of Nichi-Iko Pharmaceutical Co., Ltd. and Eisai Co., Ltd.
Strategic Alliance Agreement for the Generic Business of Nichi-Iko Pharmaceutical Co., Ltd. and Eisai Co., Ltd. - Aiming to Create New Business Models and Expand Contribution to Patients - March 29, 2018
More informationGlobal and China Industrial Robot Speed Reducer Industry Report, Jun. 2014
Global and China Industrial Robot Speed Reducer Industry Report, 2013-2016 Jun. 2014 STUDY GOAL AND OBJECTIVES This report provides the industry executives with strategically significant competitor information,
More information